Yang H, Zhou P and Huang H contributed equally to this work.
1097-0215/asset/olbannerleft.jpg?v=1&s=45719cd7de57873027993264fcc568b335a8cd56)
1097-0215/asset/olbannerright.jpg?v=1&s=5e0fba63c1309b3036eb9215a0e1e83dd02efd19)
Cancer Therapy
You have full text access to this OnlineOpen article
Shikonin exerts antitumor activity via proteasome inhibition and cell death induction in vitro and in vivo
Article first published online: 3 DEC 2008
DOI: 10.1002/ijc.24195
Copyright © 2008 Wiley-Liss, Inc.
Additional Information
How to Cite
Yang, H., Zhou, P., Huang, H., Chen, D., Ma, N., Cui, Q. C., Shen, S., Dong, W., Zhang, X., Lian, W., Wang, X., Dou, Q. P. and Liu, J. (2009), Shikonin exerts antitumor activity via proteasome inhibition and cell death induction in vitro and in vivo. Int. J. Cancer, 124: 2450–2459. doi: 10.1002/ijc.24195
- †
Yang H, Zhou P and Huang H contributed equally to this work.
- ‡
Fax: 313-576-8307
Publication History
- Issue published online: 16 MAR 2009
- Article first published online: 3 DEC 2008
- Accepted manuscript online: 3 DEC 2008 12:00AM EST
- Manuscript Accepted: 19 NOV 2008
- Manuscript Received: 7 AUG 2008
Funded by
- The National High Technology Research and Development Program of China. Grant Number: 2006AA02Z4B5
- National Natural Science Foundation of China. Grant Number: 30770835
- State Education Ministry (Scientific Research Foundation)
- Department of Defense Breast Cancer Research Program. Grant Numbers: W81XWH-04-1-0688, DAMD17-03-1-0175
- National Cancer Institute. Grant Number: 1R01CA120009
- National Cancer Institute/NIH Cancer Center
References
- 1,,,,,,,. Shikonin, a component of Chinese herbal medicine, inhibits chemokine receptor function and suppresses human immunodeficiency virus type 1. Antimicrob Agents Chemother 2003; 47: 2810–6.
- 2,,,. Cellular pharmacology studies of shikonin derivatives. Phytother Res 2002; 16: 199–209.
- 3,,,. Shikonins, phytocompounds from Lithospermum erythrorhizon, inhibit the transcriptional activation of human tumor necrosis factor alpha promoter in vivo. J Biol Chem 2004; 279: 5877–85.
- 4,. Inhibition of tumor necrosis factor-alpha through selective blockade of Pre-mRNA splicing by shikonin. Mol Pharmacol 2007; 71: 1640–5.
- 5,,,,,. Antimicrobial activities of naphthazarins from Arnebia euchroma. J Nat Prod 2002; 65: 1857–62.
- 6,,. In vitro antifungal activity of naphthoquinone derivatives. Biol Pharm Bull 2002; 25: 669–70.
- 7,,,,. Antitumor activity of shikonin and its derivatives. Chem Pharm Bull 1977; 25: 2392–5.
- 8,,,,,. Shikonin regulates HeLa cell death via caspase-3 activation and blockage of DNA synthesis. J Asian Nat Prod Res 2004; 6: 155–66.
- 9,,,,,,,. Shikonin-induced apoptosis involves caspase-3 activity in a human bladder cancer cell line (T24). In Vivo 2007; 21: 1011–9.
- 10,,,,. Shikonin, an ingredient of Lithospermum erythrorhizon induced apoptosis in HL60human premyelocytic leukemia cell line. Planta Med 1999; 65: 532–5.
- 11,,,,,,,. Shikonin circumvents cancer drug resistance by induction of a necroptotic death. Mol Cancer Ther 2007; 6: 1641–9.
- 12,,,,. Induction of topoisomerase II-mediated DNA cleavage by the plant naphthoquinones plumbagin and shikonin. Antimicrob Agents Chemother 1992; 36: 2589–94.
- 13,,,,,,,,. Growth inhibition and induction of apoptosis in human oral squamous cell carcinoma Tca-8113 cell lines by shikonin was partly through the inactivation of NF-kappaB pathway. Phytother Res 2008; 22: 407–15.
- 14,,,,,. p53-Mediated cell cycle arrest and apoptosis induced by shikonin via a caspase-9-dependent mechanism in human malignant melanoma A375-S2 cells. J Pharmacol Sci 2004; 94: 166–76.
- 15,,,. Direct reaction between shikonin and thiols induces apoptosis in HL60 cells. Biol Pharm Bull 2002; 25: 827–32.
- 16,,,,,,. Involvement of reactive oxygen species, but not mitochondrial permeability transition in the apoptotic induction of human SK-Hep-1 hepatoma cells by shikonin. Planta Med 2003; 69: 1119–24.
- 17
- 18. The development of proteasome inhibitors as anticancer drugs. Cancer Cell 2004; 5: 417–21.
- 19,,. Drug discovery in the ubiquitin-proteasome system. Nat Rev Drug Discov 2006; 5: 596–613.
- 20,,,. Interruption of tumor cell cycle progression through proteasome inhibition: implications for cancer therapy. Prog Cell Cycle Res 2003; 5: 441–6.
- 21,. Catalytic activities of the 20 S proteasome, a multicatalytic proteinase complex. Arch Biochem Biophys 2000; 383: 1–16.
- 22,,,,. Molecular machines for protein degradation. Chembiochem 2005; 6: 222–56.
- 23,,,,. Celastrol, a triterpene extracted from the Chinese “Thunder of God Vine,” is a potent proteasome inhibitor and suppresses human prostate cancer growth in nude mice. Cancer Res 2006; 66: 4758–65.
- 24,,,,,. Docking studies and model development of tea polyphenol proteasome inhibitors: applications to rational drug design. Proteins 2004; 54: 58–70.
- 25,,,,. Inhibition of the proteasome activity, a novel mechanism associated with the tumor cell apoptosis-inducing ability of genistein. Biochem Pharmacol 2003; 66: 965–76.
- 26,. Cleavage of retinoblastoma protein during apoptosis: an interleukin 1 beta-converting enzyme-like protease as candidate. Cancer Res 1996; 56: 438–42.
- 27,. Bax degradation by the ubiquitin/proteasome-dependent pathway: involvement in tumor survival and progression. Proc Natl Acad Sci USA 2000; 97: 3850–5.
- 28,,. Preconditioning attenuates apoptosis and necrosis: role of protein kinase C epsilon and -delta isoforms. Am J Physiol Heart Circ Physiol 2001; 281: H404–10.
- 29,,,,. Natural proteasome inhibitors in cancer prevention and treatment. Curr Protein Pept Sci 2008; 9: 227–39.
- 30,,,,. Structure-proteasome-inhibitory activity relationships of dietary flavonoids in human cancer cells. Front Biosci 2007; 12: 1935–45.
- 31,. Cleavage of poly(ADP-ribose) polymerase: a sensitive parameter to study cell death. Biochem Cell Biol 1997; 75: 337–49.
- 32,,. Ester bond-containing tea polyphenols potently inhibit proteasome activity in vitro and in vivo. J Biol Chem 2001; 276: 13322–30.
- 33,,,,. Mechanistic studies on the inactivation of the proteasome by lactacystin: a central role for clasto-lactacystin beta-lactone. J Biol Chem 1996; 271: 7273–6.
- 34,. Proteasome inhibitors in cancer therapy: lessons from the first decade. Clin Cancer Res 2008; 14: 1649–57.
- 35,. Role of the heat shock response and molecular chaperones in oncogenesis and cell death. J Natl Cancer Inst 2000; 92: 1564–72.
- 36,,,. Heat-shock protein 70 antisense oligomers enhance proteasome inhibitor-induced apoptosis. Biochem J 1999; 344: 477–85.
- 37. Heat shock and the heat shock proteins. Biochem J 1986; 240: 313–24.
- 38,,,,,. Resveratrol: from basic science to the clinic. Cell Cycle 2007; 6: 2495–510.